Stericycle (NASDAQ:SRCL) Issues Quarterly Earnings Results, Misses Estimates By $0.27 EPS

Stericycle (NASDAQ:SRCL) announced its quarterly earnings data on Thursday. The business services provider reported $0.56 earnings per share for the quarter, missing analysts’ consensus estimates of $0.83 by ($0.27), Morningstar.com reports. The firm had revenue of $845.80 million during the quarter, compared to analyst estimates of $843.95 million. Stericycle had a negative net margin of 8.92% and a positive return on equity of 12.56%. The firm’s revenue for the quarter was down 4.2% on a year-over-year basis. During the same period in the prior year, the company posted $1.17 earnings per share. Stericycle updated its FY19 guidance to $2.50-2.85 EPS.

Shares of SRCL stock traded down $1.45 during mid-day trading on Thursday, reaching $44.51. The stock had a trading volume of 4,121,310 shares, compared to its average volume of 1,047,373. The business has a fifty day moving average of $46.43. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 1.17. The company has a market cap of $4.16 billion, a price-to-earnings ratio of 10.00, a price-to-earnings-growth ratio of 1.88 and a beta of 1.21. Stericycle has a 1-year low of $34.36 and a 1-year high of $71.43.

A number of brokerages have recently weighed in on SRCL. Robert W. Baird lowered Stericycle from a “neutral” rating to an “underperform” rating and set a $44.00 price objective on the stock. in a report on Wednesday, April 17th. ValuEngine lowered Stericycle from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 2nd. Bank of America reissued an “underperform” rating and issued a $44.00 price objective (down from $46.00) on shares of Stericycle in a report on Wednesday, July 17th. BidaskClub lowered Stericycle from a “hold” rating to a “sell” rating in a report on Tuesday, June 11th. Finally, Zacks Investment Research lowered Stericycle from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 7th. Five investment analysts have rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company’s stock. Stericycle presently has an average rating of “Hold” and an average target price of $55.67.

Hedge funds have recently made changes to their positions in the company. First Bank & Trust acquired a new stake in Stericycle during the second quarter worth about $28,000. Blue Sky Asset Management LLC acquired a new stake in Stericycle during the first quarter worth about $60,000. Quadrant Capital Group LLC grew its holdings in Stericycle by 1,186.8% during the first quarter. Quadrant Capital Group LLC now owns 1,171 shares of the business services provider’s stock worth $61,000 after acquiring an additional 1,080 shares during the period. North Star Investment Management Corp. grew its holdings in Stericycle by 667.5% during the first quarter. North Star Investment Management Corp. now owns 1,535 shares of the business services provider’s stock worth $84,000 after acquiring an additional 1,335 shares during the period. Finally, Private Capital Group LLC grew its holdings in Stericycle by 163.4% during the first quarter. Private Capital Group LLC now owns 1,641 shares of the business services provider’s stock worth $89,000 after acquiring an additional 1,018 shares during the period. 96.52% of the stock is currently owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.

See Also: What are municipal bonds?

Earnings History for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.